Wolverine Trading
HCAT icon

Wolverine Trading’s Health Catalyst HCAT Stock Holding History

Wolverine Trading’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$36.9K Buy
+12,652
New +$43.3K ﹤0.01% 5477

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wolverine Trading's HCAT Position: Q3 2025 in Review

Wolverine Trading opened a new position in Health Catalyst (HCAT) in Q3 2025: 12,652 shares worth $36.9K. The stake represents ﹤0.01% of the portfolio and ranks #5477 among its holdings.

145 funds tracked by Wall St. Rank hold HCAT as of Q3 2025.

  • Wolverine Trading held 12,652 shares of Health Catalyst worth $36.9K as of Q3 2025.
  • Health Catalyst was a new Wolverine Trading position in Q3 2025.
  • Health Catalyst made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5477 holding.
  • 145 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.